DRADS Capital logo

DRADS Capital

North America, Massachusetts, United States, Boston

Description

DRADS Capital is a Boston-based venture fund investing in life sciences, biotechnology, and A.I. company

Investor Profile

DRADS Capital has made 12 investments, with 0 in the past 12 months and 17% as lead.

Stage Focus

  • Seed (33%)
  • Series C (25%)
  • Series Unknown (25%)
  • Series D (8%)
  • Series B (8%)

Country Focus

  • United States (83%)
  • United Arab Emirates (8%)
  • South Korea (8%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
  • Neuroscience
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Food Processing
  • Nutrition
  • Plant-based Foods
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does DRADS Capital frequently co-invest with?

LP
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Nextrans
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Altium Capital
North America, New York, United States, New York
Co-Investments: 1
Colle Capital Partners
North America, New York, United States, New York
Co-Investments: 1
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 1
Axiom Associates
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Mint Venture Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Affinity Asset Advisors
North America, New York, United States, New York
Co-Investments: 1
Huami
Asia, Beijing, China, Beijing
Co-Investments: 1
Fen Ventures
South America, Region Metropolitana, Chile, Santiago
Co-Investments: 2

What are some of recent deals done by DRADS Capital?

Alsym Energy

Woburn, Massachusetts, United States

Alsym Energy develops non-lithium rechargeable batteries for stationary storage, maritime shipping, and electric vehicles.

BatteryClean EnergyEnergy StorageRenewable Energy
Series CApr 3, 2024
Amount Raised: $78,000,000
QuanticAsset

Dubai, Dubai, United Arab Emirates

QuanticAsset develops AI-driven asset management and investment products for high-net-worth family offices and institutional investors.

Artificial Intelligence (AI)FinanceFinTech
SeedJan 1, 2024
Angiowave

Cambridge, Massachusetts, United States

Angiowave Provides shockwave therapy services intended to offer safe, comfortable treatment for men to optimize sexual performance.

Health CareMedical
SeedJan 1, 2023
The Live Green Co

Boston, Massachusetts, United States

The Live Green Co is a blends nature with science & tech to make plant based foods tastier, healthier, and more sustainable.

BiotechnologyFood ProcessingNutritionPlant-Based FoodsSustainabilityWellness
SeedJan 5, 2022
Amount Raised: $7,000,000
Zammo.ai

San Francisco, California, United States

SaaS platform to create a conversational AI presence: Voice Telephony, Voice Assistants and Conversational Virtual Agents (or chatbots)

Artificial Intelligence (AI)ChatbotCreative AgencyEnterpriseGovernmentHuman Computer InteractionInformation and Communications Technology (ICT)SaaSSmart Cities
Series UnknownJan 1, 2022
The Live Green Co

Boston, Massachusetts, United States

The Live Green Co is a blends nature with science & tech to make plant based foods tastier, healthier, and more sustainable.

BiotechnologyFood ProcessingNutritionPlant-Based FoodsSustainabilityWellness
SeedSep 5, 2021
Amount Raised: $8,000,000
Hyperfine

Guilford, Connecticut, United States

Hyperfine makes MRI accessible to every patient regardless of income or resources.

ComputerHealth CareMedical Device
Series DFeb 10, 2021
Amount Raised: $90,000,000
MarvelBiome

Woburn, Massachusetts, United States

MarvelBiome focuses on isolating, identifying, and characterizing microbial populations for novel therapeutic applications.

BiopharmaBiotechnologyHealth CareMedical
Series UnknownNov 17, 2020
Amount Raised: $3,100,001
ROKIT Healthcare

Seoul, Seoul-t'ukpyolsi, South Korea

ROKIT Healthcare is a biotechnology company that offers hyper-personalized organ regenerative healthcare solutions.

BiotechnologyHealth CareMedical
Series CJul 9, 2020
Amylyx Pharmaceuticals

Cambridge, Massachusetts, United States

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

BiotechnologyMedicalNeurosciencePharmaceutical
Series BJul 1, 2020
Amount Raised: $30,000,000